| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 0 buys and 105 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $101.27B | - | |
| CEO | 515.2K | $565.95M | - | |
| VP | 137.5K | $151.03M | - | |
| Dir | 75.1K | $82.50M | - | |
| Dir | 55.5K | $60.94M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Lilly Endowment Inc | - | Sell | 167,526 | $1,051.17 | $176,098,702.11 | - | -1.3% | - | |
| Nov 18, 2025 | Lilly Endowment Inc | - | Sell | 60,213 | $1,034.78 | $62,306,968.56 | - | +0.6% | - | |
| Nov 17, 2025 | Lilly Endowment Inc | - | Sell | 9,886 | $1,030.68 | $10,189,269.49 | - | +1.4% | - | |
| Nov 14, 2025 | Lilly Endowment Inc | - | Sell | 178,295 | $605.74 | $108,000,001.85 | - | +1.3% | - | |
| Nov 13, 2025 | Lilly Endowment Inc | - | Sell | 46,606 | $1,030.26 | $48,016,098.38 | - | -0.7% | - | |
| Nov 13, 2025 | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 1,000 | $1,010.50 | $1,010,500.00 | -26.0% | -0.7% | - | |
| Nov 12, 2025 | Lilly Endowment Inc | - | Sell | 305,000 | $1,011.18 | $308,411,204.35 | - | +0.7% | - | |
| Nov 11, 2025 | Lilly Endowment Inc | - | Sell | 283,131 | $986.64 | $279,347,679.79 | - | +5.7% | - | |
| Nov 10, 2025 | Lilly Endowment Inc | - | Sell | 16,869 | $972.52 | $16,405,395.92 | - | +8.1% | - | |
| Nov 5, 2025 | Lilly Endowment Inc | - | Sell | 179,042 | $933.26 | $167,092,103.97 | - | +8.4% | - |